Spokane Regional Health District to resume use of Johnson & Johnson COVID vaccine
SPOKANE, Wash. — The Spokane Regional Health District will resume use of the Johnson and Johnson COVID-19 vaccine.
“The J&J vaccine is safe and effective,” said Interim Health Officer Dr. Frank Velazquez. “The risks are rare compared to the enormous morbidity and mortality risks associated with contracting the COVID-19 virus. It’s ease of use makes it instrumental in many of our vaccination outreach efforts.”
Earlier this month, the US announced a pause on the J&J vaccine following a few reports of blood clots. The government uncovered 15 vaccine recipients who developed the highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died and seven were hospitalized.
The 11-day federal pause was lifted on Friday, and on Saturday, Governor Jay Inslee announced J&J vaccinations would resume in Washington.
The SRHD has been using J&J vaccines for individuals who are homebound, living in congregate settings and in rural communities. This vaccine has an ability to be stored at a warmer temperature and since it only requires one dose, itr allows for faster, more efficient vaccination in these communities.
Some flu-like symptoms, such as tiredness, muscle pain, chills or fever after getting a vaccine are normal. Anyone who has received a J&J vaccine in the last three weeks should reach out to their healthcare provider if they experience severe headache, abdominal pain, leg pain or shortness of breath.
COPYRIGHT 2021 BY KXLY. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.